09.01.03
The U.S. Armed Forces Radiobiology Research Institute (AFRRI), Washington, D.C., and Biopolymer Engineering, Eagan, MN, have formed a joint agreement to research the radiation-protective characteristics of one of the company’s compounds. Earlier pre-clinical studies at the Institute support the fact that systemic (injected) administration of soluble and particulate forms of beta 1,3 glucan, obtained from yeast cell walls, can combat radiation effects, enhancing the recovery of white blood cells and increasing the survival rate in mice given a lethal dose of radiation. The first phase of the new research project will test in mice the efficacy of orally delivered WGP Glucan, a patented yeast compound manufactured by Biopolymer Engineering.